Celldex Therapeutics
CLDX
#4691
Rank
HK$15.30 B
Marketcap
HK$230.38
Share price
6.44%
Change (1 day)
11.34%
Change (1 year)

Celldex Therapeutics (CLDX) - Total assets

Total assets on the balance sheet as of September 2025 : HK$5.04 Billion

According to Celldex Therapeutics's latest financial reports the company's total assets are HK$5.04 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celldex Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$6.15 B69.15%
2023-12-31HK$3.63 B31.95%
2022-12-31HK$2.75 B-20.51%
2021-12-31HK$3.46 B89.65%
2020-12-31HK$1.82 B90.96%
2019-12-31HK$0.95 B-21.53%
2018-12-31HK$1.22 B-50.52%
2017-12-31HK$2.46 B-17.05%
2016-12-31HK$2.97 B13.62%
2015-12-31HK$2.61 B36.01%
2014-12-31HK$1.92 B-28.53%
2013-12-31HK$2.69 B176.59%
2012-12-31HK$0.97 B27.85%
2011-12-31HK$0.76 B-11.04%
2010-12-31HK$0.85 B-21.39%
2009-12-31HK$1.08 B101.8%
2008-12-31HK$0.53 B637.86%
2007-12-31HK$73.09 M-84.71%
2006-12-31HK$0.47 B69.19%
2005-12-31HK$0.28 B-20.6%
2004-12-31HK$0.35 B46.69%
2003-12-31HK$0.24 B-11.69%
2002-12-31HK$0.27 B-34.12%
2001-12-31HK$0.41 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Seagen
SGEN
HK$28.28 B 460.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$1.82 B-63.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$11.37 B 125.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$701.57 B 13,801.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.624 T 32,089.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$641.79 B 12,616.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
HK$23.74 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA